Topological Analysis of the baseline characteristics of relapsed and/or refractory multiple myeloma (R/R MM) patients treated with carfilzomib in clinical trials to identify cohorts that represent levels of risk of select cardiovascular adverse events (CV AEs) in that patient population (20190506)

ENCePP Code of conduct

No

Data sources

• Data source(s), other:
  ARROW study, ASPIRE study, ENDEAVOR study, FOCUS study
• Data sources (types):
  Other
• Data sources (types), other:
  Phase 3 randomized clinical trials

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No